Dr. Minniti, Professor of Medicine and Pediatrics at Albert Einstein College of Medicine, formerly the Director of the Sickle Cell Center for Adults at Montefiore Medical Center, whose mission is to provide exceptional, seamless, comprehensive, compassionate and individualized care, education, counseling and research for people living with sickle cell disease. Dr. Minniti is a clinical trial specialist and a translational researcher who believes that the best way to provide care for SCD patients is a continuum, from birth to adulthood.
The focus of her research is in understanding mechanisms that lead to end organ damage in order to identify early biomarkers and targeted therapies. Her interests have spanned from stroke to pulmonary hypertension and most recently, she has focused on leg ulcers as they represent a window into the vasculopathy in SCD. She aims to develop pathogenetically based therapeutic approaches for preventing and treating SCD-related end organ damage. Before moving to New York, she was a member of the Hematology Branch of the National Institute of Heart Blood and Lung, where she developed a topical treatment for chronic leg ulcers in SCD. Her contributions have been recognized by the American Society of hematology, as and invited member of the Sickle Cell Disease Clinical Endpoints Workshop in 2019 and by the leadership of NHLBI as an incoming member of the NIH Sickle Cell Disease Advisory Committee in 2019. Dr Minniti has received recognitions from her peers, as Scientific Chair of the 2019 Foundation for Sickle Cell Disease Symposium and from patient’s organizations, as recipient of the Sickle Cell Thalassemia Patient Network of New York “Distinguished Service Award” in 2018. She is the author of more than 150 peer reviewed articles and several book chapters. She is particluly interested in devloping new paradigns for the evaluation and treatment of patients with Sickle Cell and Leg Ulcers.